Bausch Health Announces Participation in Upcoming Investor Conferences

LAVAL, QC, March 3, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate at two upcoming investor conferences.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the virtual Cowen & Co. 42^nd Annual Health Care Conference on March 8, 2022 at 12:50 p.m. ET and at the Barclays Global Healthcare Conference 2022 in Miami on March 15, 2022 at 11:15 a.m. ET.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301493445.html

SOURCE Bausch Health Companies Inc.